glp 1 breast cancer A trio of large observational studies reported at the San Antonio Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two studies GLP-1 Receptor Agonists in Breast

ongoing monitoring is still needed Bariatric surgery may be considered for severe obesity Medications First-line medication Reduces CSF production Start low, increase gradually Side effects: tingling, carbonated drinks taste flat, kidney stones Alternative or addition to acetazolamide May help with headache Can cause weight loss (advantage in IIH) Side effects: cognitive slowing, tingling Furosemide Sometimes added to acetazolamide Monitor potassium GLP-1 Receptor Agonists (Emerging Treatment) GLP-1 medications (such as semaglutide, sold as Ozempic or Wegovy) are showing significant promise for IIH

Bliddal, H., Leeds, A

10.1123/ijsnem.20.6.457 158 WilloughbyD

This study tested the hypothesis that glycine supplementation enhances the activities of creatine- and GSH-forming enzymes as well as creatine and GSH availabilities in tissues of hybrid striped bass (HSB